Repligen
RGEN
S$161.33
Share price
4.72%
Change (1 day)
-12.88%
Change (1 year)
Categories
Repligen (RGEN) - Total assets
Total assets on the balance sheet as of March 2025 : S$3.67 Billion
According to Repligen 's latest financial reports the company's total assets are S$3.67 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Repligen - Total assets on balance sheet (from 2001 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | S$3.84 B | 2.87% |
| 2023-12-31 | S$3.73 B | 10.17% |
| 2022-12-31 | S$3.39 B | 6.45% |
| 2021-12-31 | S$3.18 B | 26.65% |
| 2020-12-31 | S$2.51 B | 33.37% |
| 2019-12-31 | S$1.88 B | 78.37% |
| 2018-12-31 | S$1.05 B | 6.41% |
| 2017-12-31 | S$0.99 B | 137.83% |
| 2016-12-31 | S$0.41 B | 102.14% |
| 2015-12-31 | S$0.20 B | 22.03% |
| 2014-12-31 | S$0.16 B | 12.77% |
| 2013-12-31 | S$0.15 B | 26.71% |
| 2012-12-31 | S$0.11 B | |
| 2011-03-31 | S$91.09 M | -8.72% |
| 2010-03-31 | S$99.79 M | -10.92% |
| 2009-03-31 | S$0.11 B | 18% |
| 2008-03-31 | S$94.94 M | 115.24% |
| 2007-03-31 | S$44.11 M | -5.22% |
| 2006-03-31 | S$46.54 M | 1.66% |
| 2005-03-31 | S$45.78 M | -7.47% |
| 2004-03-31 | S$49.47 M | 4.58% |
| 2003-03-31 | S$47.31 M | -11.98% |
| 2002-03-31 | S$53.74 M | -7.9% |
| 2001-03-31 | S$58.35 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Novavax NVAX | S$1.66 B | -54.67% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | S$9.20 B | 150.58% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | S$4.74 B | 29.30% | 🇺🇸 USA |
 General Electric GE | S$159.81 B | 4,251.93% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | S$127.52 B | 3,372.52% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | S$119.00 B | 3,140.62% | 🇺🇸 USA |
 Pfizer PFE | S$267.84 B | 7,193.75% | 🇺🇸 USA |
 Bio-Techne TECH | S$3.40 B | -7.29% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | S$0.11 B | -96.98% | 🇺🇸 USA |
 Charles River Laboratories
CRL | S$9.76 B | 165.85% | 🇺🇸 USA |